FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
1.132 |
Evidence |
|
C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
GNAI2 |
Galphai2 protein |
1.132 |
Evidence |
|
AZGP1 |
AZGP1, tcag7.638: Alpha-2-glycoprotein 1, zinc-binding |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
1.132 |
Evidence |
|
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
MAPK8 |
MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 |
PTEN |
PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du |
1.132 |
Evidence |
|
IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
THPO |
THPO, MGDF: Thrombopoietin precursor |
1.132 |
Evidence |
|
TNFSF13B |
TNFSF13B, BAFF, UNQ401/PRO738, BLYS, TALL1, TNFSF20, ZTNF4: Tumor necrosis facto |
TNFRSF10C |
TNFRSF10C, DCR1, UNQ321/PRO366, LIT, TRAILR3, TRID: Tumor necrosis factor recept |
1.132 |
Evidence |
|
CASP1 |
CASP1, IL1BC, IL1BCE: Caspase-1 precursor |
PEA15 |
PEA15: Astrocytic phosphoprotein PEA-15 |
1.132 |
Evidence |
|
PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINA6 |
SERPINA6, CBG: Corticosteroid-binding globulin precursor |
1.132 |
Evidence |
|
CASP9 |
CASP9, MCH6: Caspase-9 precursor |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
1.132 |
Evidence |
|
HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
SERPINA4 |
SERPINA4, KST, PI4: Kallistatin precursor |
1.132 |
Evidence |
|
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
1.132 |
Evidence |
|
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
MLXIPL |
MLXIPL, MIO, WBSCR14: Williams-Beuren syndrome chromosome region 14 protein |
1.132 |
Evidence |
|
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
1.132 |
Evidence |
|
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
1.132 |
Evidence |
|
ZNF267 |
ZNF267: Zinc finger protein 267 |
ZNF174 |
ZNF174, ZSCAN8: Zinc finger protein 174 |
1.132 |
Evidence |
|
IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
IL2 |
IL2: Interleukin 2 |
1.132 |
Evidence |
|
KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
RYR2 |
RYR2: Ryanodine receptor 2 |
1.132 |
Evidence |
|
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
1.132 |
Evidence |
|
IL3 |
IL3: Interleukin-3 precursor |
IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
1.132 |
Evidence |
|
TRPV4 |
TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb |
TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
1.132 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
1.132 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
1.132 |
Evidence |
|
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|